supplymentary tables

Research hypothesis: We investigated the association between herpetic infections and therapies involving biologics or Janus kinase inhibitors in patients with atopic dermatitis.
Table S1. This table shows 13 selected PT entries associated with herpesvirus infections and indicates which PT entries are included in each of the four major categories.
Table S2. The table illustrates the 2x2 contingency table used for adverse drug reaction assessment, defining the elements a, b, c, d, and N, and detailing the computational procedure for a, b, c, and d in each stratified category.
Table S3. This table shows the positive criteria for the four signal detection methods used in this study: ROR, PRR, EBGM, and IC.

研究假说：本研究探讨了特应性皮炎（atopic dermatitis）患者的疱疹病毒感染与采用生物制剂（biologics）或贾纳斯激酶抑制剂（Janus kinase inhibitors）的治疗方案之间的关联。
附表S1：本附表列出了13个与疱疹病毒感染相关的经筛选的首选术语（Preferred Term，PT）条目，并指明了四大类别中各自包含的PT条目。
附表S2：本附表展示了用于药物不良反应（adverse drug reaction）评价的2×2列联表，明确了其中的a、b、c、d及N元素，并详细说明了各分层类别中a、b、c、d的计算流程。
附表S3：本附表列出了本研究采用的四种信号检测方法（ROR、PRR、EBGM及IC）的阳性判定标准。